Dr Arijit Bishnu is the best haemato- onchologist in Siliguri, with great skills and friendly nature.
Chemotherapy is a cornerstone treatment for many hematologic cancers, including leukemia, lymphoma, myeloma, and other blood-related malignancies. This treatment involves the use of powerful drugs designed to kill or slow the growth of cancer cells by interfering with their ability to divide and replicate. Chemotherapy can be administered intravenously, orally, or through other methods, depending on the type of cancer and the specific drugs used. It is typically used in combination with other treatments such as radiation therapy, stem cell transplants, or immunotherapy to increase effectiveness and improve patient outcomes. While chemotherapy is highly effective in treating hematologic cancers, it also affects normal, healthy cells that divide rapidly, which can lead to side effects. Common side effects include nausea, vomiting, hair loss, fatigue, infection risk, and anemia. These side effects are often temporary, but they can significantly impact a patient's quality of life. Supportive care, including anti-nausea medications, growth factors to stimulate blood cell production, and transfusions, is often used to help manage these symptoms.
Chemotherapy can be used in various treatment phases, including induction therapy to achieve remission, consolidation therapy to eliminate remaining cancer cells, and maintenance therapy to prevent relapse. The specific chemotherapy regimen depends on the type of blood cancer and the patient's individual health status. Despite its potential for side effects, chemotherapy remains a vital and effective treatment, providing hope for many patients by inducing remission and prolonging life.
Dr. Arijit Bishnu and his team use advanced diagnostics, such as genetic testing and molecular profiling, to determine whether targeted therapy is right for a patient. Treatment is then closely monitored and adjusted based on response and tolerance :
Medical History Review: Understanding your symptoms, lifestyle, and medical history to assess any underlying conditions that may be contributing to the menstrual issues.
Treatment of specific blood cancers - Used in conditions such as chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), certain lymphomas, and myeloproliferative neoplasms.
Molecular targeting - Focuses on proteins, genes, or cellular pathways that drive abnormal blood cell growth or survival.
Genetic testing required -Requires molecular diagnostics to identify the presence of targetable mutations or markers.
Fewer side effects than chemotherapy - Typically spares normal cells, leading to lower risk of hair loss, nausea, or widespread immune suppression.
Key advancement in personalized medicine - Allows hematologists to match treatment to each patient’s unique disease profile for optimal outcomes.
© Dr. Arijit Bishnu. All Rights Reserved.
Designed by Digiex Web